UPDATE 1-Merck stops giving clot drug in study, shares drop

NEW YORK, Jan 13 (Reuters) - Merck & Co said on Thursday it stopped giving one of its most important experimental drugs, the blood clot preventer Vorapaxar, to patients in one study and to some patients in another late-stage trial.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.